| abstract |
A GRK2 protein inhibitor compound of Formula Iwherein X is an atom selected from carbon and nitrogen, andR1 is selected from the groups methyl carboxylate and 1,3,4-oxadiazol-2-yl and wherein the compound is selected from methyl 4-(naphthalene-2-amido)benzoate and N-[4-(1,3,4-oxadiazol-2-yl)phenyl]quinoline-3-carboxamide. Also disclosed are pharmaceutical compositions comprising at least a compound of Formula I. |